Natera (NASDAQ:NTRA – Free Report) had its price objective hoisted by The Goldman Sachs Group from $90.00 to $100.00 in a research note released on Monday morning, Benzinga reports. The Goldman Sachs Group currently has a buy rating on the medical research company’s stock. NTRA has been the subject of several other reports. Craig Hallum […]
Natera, Inc. (NASDAQ:NTRA – Free Report) – Equities research analysts at Leerink Partnrs dropped their Q4 2024 earnings per share (EPS) estimates for shares of Natera in a research note issued on Monday, April 1st. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will post earnings per share of ($0.44) for […]
Natera (NASDAQ:NTRA) Shares Gap Up to $92.36 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Natera (NASDAQ:NTRA) Reaches New 52-Week High at $96.80 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Natera, Inc. (NASDAQ:NTRA – Get Free Report) has received a consensus rating of “Moderate Buy” from the thirteen analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating on the company. The average 1-year target price among […]